1-4 of 4
Louis Fehrenbacher, MD
Close
Sort by
Journal Articles

Tositumomab and I 131 Tositumomab Achieves Complete Remissions Lasting > 10 Years In Patients with Chemotherapy-Refractory Low-Grade and Transformed B-Cell Lymphomas

Mark S. Kaminski, MD, Andrew D. Zelenetz, MD, Oliver W. Press, MD, PhD, Mansoor N. Saleh, MD, John P. Leonard, MD, Louis Fehrenbacher, MD, T. Andrew Lister, MD, Thierry J. Horner, PhD, Vanessa C. Williams, MS, Thomas S. Lin, MD, PhD, Christina Vleisides, DC, Susan J. Knox, MD, PhD, Richard L. Wahl, MD, Julie M. Vose
Journal: Blood
Blood (2010) 116 (21): 3960.
https://doi.org/10.1182/blood.V116.21.3960.3960
Published: 2010
Journal Articles

Rituximab Therapy after Response to R-CHOP Induction Therapy for Patients with Previously Untreated Indolent Non-Hodgkin’s Lymphoma (NHL): Clinical Outcomes and Pharmacokinetics (PK)

Louis Fehrenbacher, MD, Jonathan A. Polikoff, MD, Robert Hermann, MD, Haresh Jhangiani, MD, Jean Bjerke, MD, David Loeck, MD, Lowell Hart
Journal: Blood
Blood (2007) 110 (11): 1295.
https://doi.org/10.1182/blood.V110.11.1295.1295
Published: 2007
Journal Articles

Tositumomab and Iodine I 131 Tositumomab (The BEXXAR® Therapeutic Regimen) Produced Ongoing, Durable Remissions of More Than 5 Years in 9 Patients with Non-Hodgkin’s Lymphoma (NHL) in a Pivotal Study of Patients Refractory to Their Last Chemotherapy.

Mark S. Kaminski, MD, Andrew D. Zelenetz, MD, Oliver W. Press, MD, Mansoor N. Saleh, MD, John P. Leonard, MD, Louis Fehrenbacher, MD, T. Andrew Lister, MD, Stewart Kroll, PhD, Richard L. Wahl, MD, Susan J. Knox, MD, Julie M. Vose, MD.
Journal: Blood
Blood (2004) 104 (11): 2631.
https://doi.org/10.1182/blood.V104.11.2631.2631
Published: 2004
Journal Articles

Rituximab Plus CHOP Followed by Maintenance Rituximab as Initial Therapy for Advanced Stage Indolent Non-Hodgkin’s Lymphoma (NHL); Initial Results of Induction Therapy in a Phase II Study.

Jane E. Huang, MD, Lowell Hart, MD, Jonathon Polikoff, MD, Virginia Langmuir, MD, Fan Zhang, Louis Fehrenbacher, MD
Journal: Blood
Blood (2004) 104 (11): 4615.
https://doi.org/10.1182/blood.V104.11.4615.4615
Published: 2004